Scimplify, a Bengaluru-based startup specializing in specialty chemicals and advanced materials, has raised $25 million to scale its AI-assisted manufacturing platform, according to TechCrunch. The funding comes as the company's annualized revenue run rate — a full-year figure extrapolated from recent performance rather than booked annual revenue — has tripled to $200 million, and Scimplify is now preparing a larger push into the United States.

A Booking Platform for Chemical Plants

Scimplify operates a model that resembles a booking platform for chemical plants. Rather than owning most of the factories it works with, the company rents spare capacity, coordinates production, and sells the output to buyers around the world. That structure inverts the traditional chemical industry playbook, in which producers typically own and operate their own plants, and it lets Scimplify scale output without absorbing the capital cost of building facilities itself.

The platform, known as ATOMS, covers sourcing, research and development, and contract manufacturing of specialty chemicals and advanced materials. Production runs through a network of 200 to 550 partner facilities, most of them in India. On top of that network, Scimplify applies its own layer of science, employing more than 50 in-house R&D scientists.

Its customer base spans pharmaceuticals, agrochemicals, personal care, semiconductors, batteries, defense, and AI infrastructure.

The AI component is internal. Scimplify uses the technology to accelerate chemical synthesis, fine-tune manufacturing processes, and predict where one material can stand in for another.

The Numbers Behind the Raise

Before this round, Scimplify had raised approximately $53–54 million in total across multiple funding rounds. That total included a $9.4 million Series A and a $40 million Series B in March 2025, at a post-money valuation of roughly $150 million. The reporting does not attach a valuation to the new $25 million round.

Earlier reporting indicated the company was in discussions for a Series C in 2026, aimed at raising between $19 million and $40 million at post-money valuations of $245 million to $300 million.

On the revenue side, Scimplify's FY25 operating revenue — the Indian fiscal year ended March 2025 — came in at Rs 200 crore (one crore equals ten million), or approximately $24 million. TechCrunch now places the annualized run rate at $200 million following the tripling. Roughly 40% of revenue now comes from high-value segments: AI, semiconductors, and defense.

Why Chemicals Are Suddenly a Tech Story

Scimplify has developed capabilities for producing chemicals used in sub-10nm semiconductor manufacturing — a reference to process nodes measured below ten nanometers, the scale of advanced chip fabrication, where the chemicals involved must meet exacting purity requirements. Its footprint already reaches more than 35 countries, with offices in the US, Japan, the UAE, and Indonesia, and expansion underway in the US, Japan, and Europe. How the new capital is deployed across that expansion, and whether the roughly 40% share from AI, semiconductors, and defense shifts further, will be the figures to watch as the company's earlier-reported Series C discussions for 2026 come into view.

The company was founded by Sachin Santhosh, Salil Srivastava, and Dheeraj Dhingra.

Source: CryptoBriefing